Plenty of news due the remainder of this quarter in addition to...

Plenty of news due the remainder of this quarter in addition to new product details.

I am looking forward to the Ginko autoimmune program first results update.
Ginko which has Bill Gates as a major investor invested $5 mil into the IPO of Microba to secure this partnership.
Basically Ginko has indirectly financed Microba's interest in the partnership.
This could be a further share price catalyst.

Also further details on the launch of the Iritable Bowel Syndrome Phase 1 trial. MAP 315

Also, further distribution agreements could be announced as Microba becomes the gut microbiome testing facility of choice worldwide.